The Orthopedic Residency and Hematology-Oncology Fellowship programs will equip physicians with the expertise needed to meet global healthcare standards

Abu Dhabi, February 15, 2025: Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, has achieved a significant milestone in healthcare education by receiving accreditation from the National Institute for Health Specialties (NIHS), a prestigious accreditation program in the UAE. The two specialized medical training programs—Orthopedic Residency and Hematology-Oncology Fellowship—have secured this accreditation. The Hematology-Oncology Fellowship marks a milestone for Burjeel Holdings as the first healthcare provider in the UAE to achieve this recognition, while the accreditation for the Orthopedic Residency sets a precedent in Abu Dhabi’s private healthcare sector.

The accreditation was officially conferred by Dr. Mohammed Al Houqani, Secretary General of NIHS during a ceremony attended by Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, H.E. Dr. Rashed Alsuwaidi, the Acting Director General of Healthcare Regulatory at Department of Health – Abu Dhabi, Mr. John Sunil, Group CEO of Burjeel Holdings, and Mr. Safeer Ahamed, Group Co-CEO of Burjeel Holdings.

Dr. Mohammed Al Houqani praised Burjeel Holdings’ role in advancing medical education, highlighting its significant contributions to training the healthcare workforce and equipping them with the highest global standards. He emphasized the Group’s efforts in creating an ideal training environment based on best medical practices, which will strengthen the healthcare sector with specialized and qualified physicians capable of delivering high-quality medical services for healthcare challenges.

Speaking about this achievement, Dr. Tahani Al Qadiri, Group Director of Emiratization and Academics at Burjeel Holdings, said that this accreditation is a testament to Burjeel’s commitment to raising the next generation of specialized healthcare professionals in the region. “This milestone not only strengthens our position as a leader in private-sector medical education but also contributes significantly to Abu Dhabi’s healthcare ecosystem by nurturing highly skilled specialists,” she added.

These specialized programs will provide rigorous, hands-on training for medical residents and fellows, equipping them with the expertise required to meet global healthcare standards. The Orthopedic Residency Program will prepare aspiring trainees with comprehensive clinical experience, while the Hematology-Oncology Fellowship Program will cultivate highly specialized expertise in cancer care.

According to Prof. Humaid Al Shamsi, CEO of Burjeel Cancer Institute, the initiative will contribute to better patient outcomes. “By establishing the first accredited Hematology-Oncology Fellowship Program in the private sector in the country, we are creating a structured pathway for developing highly skilled oncologists who will play a crucial role in enhancing cancer care in the region,” he said.

Dr. Mohamed Muath ADI, Consultant Orthopedic Surgeon at Burjeel Medical City (BMC) and Program Director of the Orthopedic Residency Program, said that this milestone will enhance the quality of orthopedic education and training in the region, further elevating the standard of orthopedic care in the UAE.

This accreditation, aligning with the UAE’s strategic vision to advance the healthcare sector, reflects Burjeel’s commitment to advancing medical education, and positioning Abu Dhabi as a hub for world-class medical training.

The Group’s flagship BMC to provide a comprehensive training program, enhancing the expertise of healthcare professionals in Egypt and the region.

Dubai, UAE, January 30, 2025: In a significant step towards strengthening healthcare collaboration, the Ministry of Health, Egypt and Burjeel Holdings, a leading super-specialty healthcare services provider in the MENA region, have signed a Memorandum of Understanding (MoU) at Arab Health 2025. The agreement paves the way for a strategic partnership aimed at expanding access to advanced oncology care across Africa, with a particular focus on developing a comprehensive Bone Marrow Transplant (BMT) Program. This initiative will be spearheaded by Burjeel Medical City (BMC), the flagship facility of Burjeel Holdings, supported by Burjeel Cancer Institute, the largest integrated cancer care network in the UAE.

The agreement was signed by Dr. Maha Ibrahim, Head of the Secretariat of Specialized Medical Centers, Ministry of Health, Egypt, and Mr. John Sunil, Group CEO of Burjeel Holdings, in the presence of H.E. Khaled Abdel Ghaffar, Deputy Prime Minister and Minister of Health and Population of Egypt, Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, Mr. Omran Al Khoori, Member of the Board of Directors, Burjeel Holdings, and Mr. Safeer Ahamed, Group Co-CEO, Burjeel Holdings.

Focus on Bone Marrow Transplants

As part of the commitment to improving patient outcomes, the collaboration will develop a dedicated strategy to address and reduce the backlog of BMT patients in Egypt, ensuring timely access to life-saving procedures. Under this initiative, Burjeel Holdings will leverage its expertise from its highly successful BMT program at BMC to establish a world-class transplant unit in Egypt. The program will integrate proven protocols, advanced treatment methodologies, and multidisciplinary clinical approaches to enhance patient care and improve transplant success rates.

Comprehensive training for adult and pediatric BMT programs will be provided, empowering physicians, nurses, lab technicians, and supporting services in Egypt. The training will include hands-on experience in cutting-edge transplant techniques, post-transplant care, and multidisciplinary patient management, ensuring that local medical professionals are equipped with the latest advancements in BMT care.

Furthermore, the MoU paves the way for a research partnership between the Health Ministry and BMC, focusing on pioneering cancer treatments such as CAR-T cell therapy to advance Egypt’s capabilities in next-generation oncology solutions and innovative therapies.

Speaking on the occasion, H.E. Khaled Abdel Ghaffar stated, “This partnership with Burjeel Holdings underscores our commitment to enhancing healthcare accessibility and innovation in Egypt. By leveraging their expertise in oncology care, BMT program, and medical training, we aim to bring the highest standards of cancer treatment to our patients.”

Oncology Nursing Training, Technology Integration

In addition to BMT training, the partnership will extend specialized training to radiation oncology staff on advanced techniques, including stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) using the cutting-edge BrainLab system. To enhance diagnostic and precision medicine capabilities, staff will also receive training in molecular lab techniques, molecular pathology, and digital pathology, in collaboration with OncoHelix.

A one-year specialized oncology nursing training program will be launched, further strengthening the expertise of healthcare professionals in Egypt and the region. The initiative will also support the recruitment of oncology-trained nurses and facilitate authority accreditation, reinforcing long-term collaboration in cancer care.

Dr. Shamsheer Vayalil said, “We are honored to collaborate with the Ministry of Health, Egypt, in driving transformative changes in oncology care. Through strategic initiatives in training, research, and patient access, we look forward to making a meaningful impact in cancer treatment in Egypt.”

Additionally, a medical tourism framework will be established between the Ministry, designated agents, and BMC to enhance oncology care accessibility for patients across Africa. This initiative aligns with Egypt’s healthcare transformation goals, ensuring sustainable growth, stronger partnerships, and expanded access to specialized oncology care.

The agreement marks a significant milestone in Egypt’s healthcare advancement. By integrating expertise, cutting-edge technology, and world-class training programs, this collaboration between the Ministry of Health and Burjeel Holdings is set to redefine cancer care in the region.

Despite the gruelling treatments, Khaled refused to lose hope and drew strength from his faith and the unwavering support of friends, fellow survivors

Published: Thu 15 Feb 2025

A young UAE footballer’s life took an unexpected turn when persistent headaches, extreme sensitivity to light and sound, and constant nausea led to a shocking diagnosis. At just 26, Khaled (name changed) was diagnosed with a rare and aggressive brain tumour.

While working as an administrative employee, his true passion remained on the football field, where he played semi-professionally for Al Wahda and Baniyas Clubs in the UAE.

“I was at the start of my life, with so many dreams ahead of me. When I heard I had brain cancer, it felt like my world had stopped,” said Khaled. What followed was a gruelling battle involving multiple surgeries and years of radiation therapy as he fought anaplastic ependymoma with RELA fusion.

Advanced imaging revealed a large mass in his brain, requiring immediate surgery at Burjeel Hospital. He was then transferred to the Burjeel Cancer Institute (BCI) at Burjeel Medical City for specialized oncological care.

After a comprehensive pathology review, doctors recommended targeted radiation therapy. His initial treatment, completed in early 2021, showed promising results, with no immediate signs of disease progression. But by the end of the year, the aggressive tumour made a devastating comeback.

Race against time

New scans revealed five additional lesions in his brain, requiring a second surgery. Due to their locations and sizes, only three out of the five lesions could be removed. Doctors also found that the disease had spread aggressively, with multiple smaller lesions scattered throughout his brain.

After a detailed review by a multidisciplinary tumour board, a second round of radiotherapy was recommended, this time covering both the brain and spinal cord. However, just two sessions into the treatment, Khaled began experiencing worsening neurological symptoms.

A follow-up scan revealed that the two remaining lesions had grown significantly, necessitating a third brain surgery.

“My body was growing weaker by the day. I was used to moving and playing sports, but this was an entirely different kind of challenge,” he said.

Fighting against the odds

Despite the gruelling treatments, Khaled refused to lose hope. He drew strength from his faith and the unwavering support of friends, especially fellow cancer survivors.

One of his biggest inspirations was former UAE footballer Fahad Masoud, who also battled cancer. “I admired him as a player and followed his journey before and after his illness. Seeing how he kept going despite his challenges truly motivated me,” said Khaled.

By 2022, he had successfully completed his second round of radiotherapy.

New lease on life

“This case challenged us both clinically and emotionally. We had to prepare Khaled and his family for the worst, yet miracles do happen. His recovery is truly a blessing,” said Dr Ibrahim Abu Gheida, chief medical officer and clinical director of Radiation Oncology.

Radiation therapy played a crucial role in Khaled’s treatment. As one of the three main pillars of cancer care, alongside surgery and chemotherapy, it helped target recurring tumours while minimising damage to surrounding healthy tissue.

“Radiation oncology is a cornerstone in the fight against cancer. Khaled’s case was particularly challenging, but our multidisciplinary approach ensured he received the best possible care,” added Dr Abu Gheida.

Back on the field

Nearly five years after his diagnosis, Khaled regained his strength, resumed exercising, and even played football recreationally. “This journey taught me patience,” he said.

His message to others fighting similar battles is simple: “You are stronger than the disease.”

Maya, a breast cancer survivor, underwent Whipple procedure to treat periampullary cancer

February 15

Abu Dhabi: In a story of resilience and courage, a 59-year-old Emirati mother of five has triumphed over a second cancer diagnosis, this time with the aid of cutting-edge robotic surgery that removed several organs with unparalleled precision.

A ‘second cancer’ refers to a new type of cancer that develops after a patient has been treated for an initial, unrelated cancer.

In this case, Maya Muhammad Al-Hajri, a breast cancer survivor from Abu Dhabi, underwent a complex 12-hour Whipple procedure using robotic technology to remove her gallbladder, parts of her pancreas, stomach, and surrounding structures, successfully treating a rare and life-threatening periampullary cancer.

Her health ordeal began seven years ago when Maya was diagnosed with breast cancer, which was treated in 2019. Despite the emotional toll of that experience, she lived a determined life only to face a new challenge.

“I thought my nightmares were over, but they weren’t,” Maya, an administrative employee, recalled.

In July 2024, Maya developed jaundice because of a blocked biliary system, which led to the discovery of a tumour in the periampullary region – the area where the bile and pancreatic ducts meet.

Surgery lasted half a day

Doctors at Burjeel Medical City (BMC) recommended the Whipple procedure – a high-risk surgery to remove the gallbladder, bile duct, part of the pancreas, stomach, small intestine, and lymph nodes. Traditionally, this procedure requires a large abdominal incision and a multidisciplinary surgical team. However, at BMC, the surgery was performed using the da Vinci robotic system, a breakthrough in minimally invasive surgery introduced at the hospital in 2023.

Maya was unperturbed by the idea of robotic surgery, understanding its numerous benefits.

“I was aware of its great advantages compared to traditional surgery, such as a reduced recovery period, smaller incisions, and lower risk of complications and bleeding. This made us confident in trusting this modern technology,” she said.

Dr Ali Iyoob, the lead surgeon, performed the procedure, which lasted about 12 hours.

“The robotic system allowed for greater precision, enhanced visualisation of intricate anatomical structures, and a reduced risk of complications,” Dr Iyoob, consultant and head of gastrointestinal surgery, said.

“Despite challenges like multiple affected lymph nodes, an enlarged liver with abnormal blood supply, multi-regional dissections, and pancreatic head resection in a confined anatomical space, the surgery went smoothly and successfully,” he noted.

Following the removal of affected organs, the surgery involved the highly complex reconstruction of the digestive pathways for food and bilio-pancreatic juices.

“Robotic technology significantly reduced the risk of inadvertent damage to surrounding organs, minimised blood loss, and improved the overall reconstruction process,” Dr Iyoob said.

The robotic approach facilitated safer and more precise reconnections of the smaller bile and pancreatic ducts, reducing the likelihood of leaks that could complicate recovery.
“Thanks to the da Vinci system, the patient’s recovery was swift. The precision and efficiency of the robotic procedure were key in allowing her to return to her daily life sooner than expected,” Dr Iyoob underlined.

Currently, Maya is leading a happy and peaceful life and is grateful for the availability of advanced robotic treatments in the country.

“I thank my sister Rahma, my family, and the medical team for their full support as I overcame my health crisis. I have made a full recovery,” Maya said.

The newly launched Burjeel Orthopedic Institute brings together a comprehensive range of offerings catering to both adults and children.

Abu Dhabi, February 7, 2025 – His Highness Sheikh Nahyan bin Zayed Al Nahyan, Chairman of the Board of Trustees of the Zayed bin Sultan Al Nahyan Charitable and Humanitarian Foundation and Chairman of the Abu Dhabi Sports Council, has inaugurated the Burjeel Orthopedic Institute at Burjeel Medical City (BMC), the flagship quaternary care facility under Burjeel Holdings. The newly launched Burjeel Orthopedic Institute, led by a team of Emirati medical experts, brings together a comprehensive range of offerings catering to both adults and children, covering orthopedic medicine and surgery, sports medicine, rehabilitation, and bone cancer treatment.

His Highness Sheikh Nahyan bin Zayed Al Nahyan toured the Institute, where he was introduced to state-of-the-art medical technologies and world-class equipment. He also met with the Institute’s medical team and gained insight into the range of orthopedic services they offer.

The event was attended by Mr. Omran Al Khoori, Member of the Board of Directors, Burjeel Holdings; Mr. John Sunil, Group CEO of Burjeel Holdings; Dr. Mohammed Qaddoura, Chief Operating Officer, Abu Dhabi Emirate & Oman, Burjeel Holdings; and Dr. Mujtaba Ali Khan, CEO of BMC. Dr. Muhammed Ateeq Al-Falahi, Director General of Zayed bin Sultan Al Nahyan Charitable and Humanitarian Foundation; and Dr. Rashed Obaid Alsuwaidi, Executive Director of Healthcare Workforce Planning Sector at the Department of Health – Abu Dhabi, were also present at the event.

Burjeel Orthopedic Institute is the latest addition to Burjeel’s suite of specialized institutes—including the Burjeel Cancer Institute, Advanced Gynecology Institute, Kypros Nicolaides Fetal Medicine and Therapy Center, Burjeel ENT Head and Neck Institute, and the Trust Fertility Clinic.

BMC, which was recently accredited as a specialized center in orthopedic care in the Emirate by the Department of Health – Abu Dhabi, integrates specialized orthopedic and surgical care enhanced by artificial intelligence technologies. It offers services in joint repair and replacement, pelvic and upper shoulder procedures, spinal surgeries, sports medicine, limb lengthening, and pediatric orthopedic care. BMC also houses the Paley Middle East Clinic, specializing in the treatment of musculoskeletal deformities in children.

According to Dr. Mohamed Muath ADI, Head of Department and Consultant Orthopedic Surgeon, the Institute integrates diagnostics, treatment, and post-rehabilitation care in a seamless, patient-centered model.

“Burjeel Orthopedic Institute provides comprehensive musculoskeletal healthcare, covering everything from initial diagnosis to post-treatment rehabilitation. At BMC, we prioritize every detail of our patients’ journey—starting from initial examinations and leveraging the latest technologies to ensure a seamless and comprehensive treatment experience tailored to the entire family. Our expertise extends across sports medicine, spine care, pediatric orthopedics, and post-surgical rehabilitation, enabling patients to lead a pain-free life with improved quality of care,” he said.

At the Institute, Dr. Mohamed Muath ADI, leads a team of world-class experts including Dr. Sidahmed Abbas, Consultant Orthopedics, Trauma; Dr. Samih Tarabichi, Consultant Orthopedic Surgery; Dr. Jaber AlKhyeli, Consultant Orthopedics; Dr. Ahmad Baha Mousa, Consultant Orthopedic Surgeon; Dr. Maged Abu-Bakr Ahmed, Specialist Orthopedic Surgery; Dr. Mohamed Abdulgaffar Elbaz, Consultant Orthopedic Surgeon; and Dr. Naveed Pasha, Specialist, Orthopedic Surgeon.

Burjeel Orthopedic Institute is equipped with the latest robotic technologies for occupational and rehabilitation therapy, including underwater hydrotherapy and advanced patient clinics designed for optimal comfort. The Institute is also committed to continuous medical research, with its experts actively participating in global medical conferences and integrating the latest advancements in orthopedic medicine and surgery.

The new center reflects Burjeel’s ongoing commitment to expanding its services and meeting the growing healthcare needs of the community with integrated, world-class medical care

Al Ain, February 11, 2025 – Burjeel Cancer Institute (BCI), the largest cancer care network in the UAE, has expanded its reach by opening a new center at Burjeel Hospital Al Ain. This strategic expansion reinforces Burjeel Holdings’ commitment to providing world-class oncology services across the country, ensuring advanced cancer care is accessible to more patients.

The inauguration ceremony was attended by Mr. John Sunil, Group CEO of Burjeel Holdings, along with distinguished guests from the Al Ain Traffic Police, Abu Dhabi Agriculture and Food Safety Authority, and Al Ain Civil Defense.

BCI, the oncology arm of Burjeel Holdings, operates from its flagship facility, Burjeel Medical City in Abu Dhabi. At the forefront of oncology treatment and research, BCI brings cutting-edge therapies and a multidisciplinary approach to patient care. The new center at Burjeel Hospital Al Ain reflects its commitment to expanding services and meeting the community’s growing healthcare needs with integrated, world-class medical care.

The newly opened center in Al Ain offers a full spectrum of oncology services, including expert consultations, state-of-the-art diagnostic capabilities and specialized treatments such as chemotherapy, immunotherapy, and targeted therapies. The institute also provides comprehensive surgical oncology services, performed by a team of leading specialists utilizing the latest medical technologies to ensure precision and efficiency. To enhance patient comfort and privacy, the facility features dedicated chemotherapy suites, creating a supportive and personalized treatment environment. The seamless integration of these services ensures that patients receive a holistic care experience, from diagnosis through recovery.

Professor Humaid bin Harmal Al Shamsi, Consultant Oncologist and CEO of Burjeel Cancer Institute, emphasized the significance of this expansion.

“The opening of BCI in Al Ain reflects our commitment to expanding oncology services and making specialized cancer care more accessible across the UAE. Our goal is to bring high-quality, patient-centered treatment closer to those in need, ensuring that individuals in Al Ain have access to the latest advancements in cancer care without the need to travel far.”

“At BCI, we prioritize a seamless patient journey from diagnosis to treatment and recovery, with a multidisciplinary approach that enhances outcomes and quality of life. To further ease access to care, we welcome patients for consultations without requiring prior appointments, reinforcing our mission to provide an integrated and patient-first experience,” he said.

Dr. Aysha Almahri, CEO – Al Ain Region, Burjeel Holdings, highlighted the institute’s impact on cancer care in the region.

“At Burjeel, we recognize that the foundation of a thriving society lies in the health and well-being of its people. Cancer care is a top priority, and this expansion ensures that more patients have access to cutting-edge therapies, reducing the need for medical travel. With the establishment of BCI in Al Ain, we reaffirm our commitment to providing world-class oncology treatments to patients across the UAE.”

With the launch of the new center in Al Ain, Burjeel Holdings continues to redefine oncology care by offering patients state-of-the-art treatment options, further solidifying the UAE’s position as a regional leader in specialized cancer care.

The lab is dedicated to the comprehensive diagnosis, treatment, and rehabilitation of balance and vertigo disorders

Abu Dhabi: Burjeel Medical City (BMC), the flagship facility under Burjeel Holdings, has unveiled a state-of-the-art Balance Lab within the Burjeel ENT Head & Neck Institute. This new facility is dedicated to the comprehensive diagnosis, treatment, and rehabilitation of balance and vertigo disorders, further strengthening BMC’s advanced offerings in otolaryngology (ear, nose, throat) and head & neck surgery.

The Balance Lab was officially opened in the presence of Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, Mr. John Sunil, Group CEO of Burjeel Holdings, alongside Dr. Mujtaba Ali Khan, CEO of BMC, and other senior officials.

“The opening of our Balance Lab represents a significant step in our ongoing commitment to delivering world-class, patient-centered care. By leveraging cutting-edge technologies and a multidisciplinary approach, we are enhancing the accuracy and precision of diagnoses while redefining the standard of care for individuals affected by balance and vertigo disorders. We are proud to lead the way in innovative healthcare, empowering our clinical teams and elevating the quality of life for every patient we serve with the highest level of expertise and support,” said Mr. John Sunil.

Specialized Focus on Balance and Vertigo Disorders

Designed to address a wide range of balance and vertigo conditions affecting all age groups, the Balance Lab utilizes a structured testing protocol to accurately diagnose and quantify the underlying causes of dizziness and imbalance. These conditions can result from various factors, including inner ear disorders, neurological issues, strokes, muscle weaknesses, and peripheral neuropathy.

The Balance Lab is equipped with state-of-the-art technology to assess and rehabilitate individuals with balance and vertigo disorders. Utilizing the latest-generation Vestibular Nystagmography (VNG), Video Head Impulse Test (VHIT), rotatory chairs, and TRV chairs specifically designed for persistent Benign Paroxysmal Positional Vertigo (BPPV), the lab accurately identifies, localizes, and quantifies balance system impairments. With tools like Computerized Dynamic Posturography, the lab can simulate various scenarios, including visual and movement-based conditions, allowing for early diagnosis of balance disorders that might otherwise remain undetected. The lab also plays a crucial role in rehabilitation, offering tailored therapy programs designed to address long-term challenges and prevent falls. These advanced tools enable early detection and precise localization of balance system impairments, facilitating targeted treatment plans and effective rehabilitation strategies.

“Our Balance Lab is a unique facility that combines all essential diagnostic and rehabilitation equipment with advanced software and functionality. This integration allows us to diagnose even the most challenging conditions early and support effective rehabilitation through a multidisciplinary approach,” said Dr. Shaik Irfan Basha, Director of the Burjeel ENT Head & Neck Institute.

Advanced Hearing Aid Services

Abu Dhabi, UAE, 26 November 2024: In a significant step toward advancing its Environmental, Social, and Governance (ESG) goals, Burjeel Holdings, a leading super-specialty healthcare services provider in the MENA region, has unveiled the ‘Better By Nature’ initiative, a program that combines environmental stewardship with employee engagement. A key highlight of the initiative is the Group’s commitment to planting a tree for every employee on their birthday— an effort expected to add approximately 13,000 trees annually to the tree cover. This not only celebrates the employees but also raises environmental awareness and contributes to enhancing the green landscape of the city. The program reaffirms the Group’s commitment to achieving carbon neutrality by 2040 and aligns with the UAE’s broader sustainability vision.

To mark the launch, Burjeel Holdings employees gathered at Jubail Mangrove Park in Abu Dhabi to plant mangroves. The event was led by Mr. Safeer Ahamed, Chief Operating Officer of Burjeel Holdings, and Mr. Muhammed Shihabuddin, Chief Financial Officer of Burjeel Holdings, underscoring the leadership’s dedication to building eco-conscious practices across the organization. 

The initiative aligns with the UAE’s ambitious goal to plant 100 million mangroves by 2030, a key component of the nation’s strategy to combat climate change and enhance biodiversity. Mangroves, often called nature’s guardians, play a critical role in sequestering carbon, protecting shorelines, and supporting diverse ecosystems. This innovative step further emphasizes Burjeel Holdings’ dedication to sustainability while actively involving its workforce toward a greener planet.

‘Better By Nature’ is part of Burjeel Holdings’ broader ESG strategy, which focuses on cultivating a Healthy Environment, Healthy Community, Healthy Governance, and Healthy System. By involving employees in meaningful ecological activities like mangrove planting, the Group aims to embed sustainability into every aspect of its operations and create a measurable environmental impact.

“At Burjeel Holdings, sustainability is more than a commitment—it is a shared responsibility and an integral part of our vision for a healthier future. Through initiatives like ‘Better By Nature,’ we are taking meaningful action to combat climate change, preserve natural ecosystems, and engage our employees in creating a positive environmental impact. This is just the beginning of our journey toward achieving carbon neutrality and aligning with the UAE’s ambitious sustainability goals,” said Mr. John Sunil, Group CEO of Burjeel Holdings. 

The Better By Nature launch event also featured activities such as kayaking and yoga sessions, building a sense of unity and well-being while reinforcing the connection between physical and environmental health.

Abu Dhabi: From the 12-week fetal scan during which a serious fetal defect was detected to undergoing in-utero surgery, a specialized EXIT procedure at birth, and major surgery to repair his diaphragm at 6 days old, baby Saif’s arrival into this world was fraught with challenges. After a 135-day stay in the NICU at Burjeel Medical City (BMC), Abu Dhabi, the little one emerged victorious, and is set to go home with his parents. Baby Saif’s parents, an Emirati couple from Al Ain, are relieved by the miraculous recovery of their newborn son following a complex medical journey that began even before his birth.

A Difficult Diagnosis

Latifa and her husband were overjoyed when they learned they were expecting their first child after five years of marriage following IVF (In vitro fertilization). Their initial excitement turned to concern at a 12-week scan when it was discovered that the baby had a serious diaphragmatic defect, causing his bowel and liver to herniate into the thorax.

The diagnosis was a blow to the couple. “It was difficult to hear that our baby might not survive due to his complex health condition or that the pregnancy might not be completed,” recalls Latifa.

They sought out specialists who could provide assistance and finally consulted Dr. Mandeep Singh, Consultant, Fetal Maternal Medicine and Obstetrics, Kypros Nicolaides Fetal Medicine and Therapy Center at BMC. Learning that specialized care was available within the country, they decided against traveling abroad for treatment.

As the pregnancy advanced, it was clear that the defect was severe, and this had led to both lungs being severely compressed. The chances of the baby surviving with such a serious defect are around 10-15%.
 Their only hope was to undergo a complex in-utero procedure called FETO procedure (Fetal endotracheal occlusion procedure), in which a balloon is placed in the baby’s trachea using a fetoscope to encourage lung growth.
Dr. Mandeep

Dr. Mandeep leads the team of doctors managing the case. Other members of the team included Dr. Iviano Ossuetta (Consultant and Director of Neonatology), Dr. Mussadaq Inayat (Consultant Neonatologist), Dr. Ahmed Omran (Consultant Obstetric Anesthesiologist), Dr. Shaikh Irfan Basha, (Consultant Otorhinolaryngology, Head & Neck Surgery), Dr. Rajasekhar Cingapagu, (Specialist, Pediatric Surgery), and Dr. Kesava Ramakrishnan (Consultant Pediatric Intensive Care Unit).

When Latifa first heard about the interventional procedure that would take place when her baby was still in her womb, she was filled with fear and anxiety. However, the medical team reassured the couple and they decided to go ahead with the procedure.

Overcoming Challenges

At 27 weeks gestation, the FETO procedure was performed successfully with the help of Dr. Mauricio Herrera (visiting physician and fetal medicine specialist). However, the mother faced a setback when she went into preterm labor shortly afterwards and started leaking amniotic fluid. With careful management, the pregnancy continued, and Latifa stayed in the hospital for the remainder of her pregnancy.

At 34 weeks, when she went into labor, the medical team performed a specialized operation known as EXIT (Ex-utero intrapartum treatment), which allowed the baby to be partially delivered while still attached to the placenta, allowing him to receive oxygen from his mother as the medical team stabilized his breathing before delivering him. During this time, Dr. Irfan Basha punctured the balloon and inserted an endotracheal tube to help Saif breathe. The baby was then delivered and transferred to the NICU. Later, baby Saif underwent major surgical repair of the diaphragm at 6 days old by Dr. Rajasekhar.

For Latifa, seeing her baby in the intensive care unit for premature babies brought mixed feelings of pain, joy, and fear. The couple traveled daily from Al Ain to Abu Dhabi to be by their baby’s side and ensure he received the best care possible. “It was a challenging time. My husband and family supported me, giving me the confidence that this would pass. The hospital felt like a second family, providing us with compassionate care. I am grateful to the UAE for its advanced healthcare system, which allowed us to stay close to our family and loved ones,” said Latifa.

Getting Ready to Go Home 

Four-and-a-half months later, baby Saif is all set to go home soon. “We are very pleased that baby Saif’s condition has greatly improved. In the last few months, he has overcome critical health challenges as our entire team worked together to deliver the best care. We are hopeful that we can continue to offer this treatment to any baby in a similar situation,” said Dr. Mandeep.

The Kypros Nicolaides Fetal Medicine & Therapy Center in Abu Dhabi has successfully managed numerous complex congenital malformations. It is one of the first centers in the UAE to perform in-utero spina bifida repair and continues to perform many such successful procedures.

UAE, Abu Dhabi:Abu Dhabi University (ADU) signed a Memorandum of Understanding (MoU) with Burjeel Holdings, a leading super-specialty healthcare services provider in MENA, to advance national research in health sciences and enhance the academic experience for university students through world-class practical expertise.

The two parties will collaborate to advance clinical studies in the UAE in line with national ambitions to become a global healthcare hub. The partnership will also increase opportunities for national and international grants for ADU students and faculty members.

Through joint initiatives, ADU and Burjeel Holdings aim to improve academic excellence and integrate industry insights to further develop curricula for students. Both parties also seek to foster innovation through collaborative research projects and the inauguration of innovative labs, advancing ADU’s standing as a hub for cutting-edge discoveries.

Abu Dhabi University continues to invest in its research capabilities to contribute to the UAE’s vision of building a knowledge-based economy. Leveraging Burjeel Holdings’ leading expertise in healthcare and the university’s world-class academic excellence, we aim to elevate the standards of research in the field of health sciences. At ADU, we are committed to creating a dynamic learning environment that adapts to the ever-evolving needs of the industry, ensuring our students are well-prepared to become the future leaders and innovators of tomorrow.
Dr. Hamad Odhabi
Vice Chancellor for Financial and Administrative Affairs of ADU

The MoU was signed by Dr. Hamad Odhabi, Vice Chancellor for Financial and Administrative Affairs of ADU, and Mr. Safeer Ahamed, Group COO of Burjeel Holdings, in the presence of Dr. Professor Ghassan Aouad, Chancellor of ADU), Salem Aldhaheri, Executive Director of Community Relations, Dr. Dr. Sofyan Maghaydah, Acting Dean of College of Health Sciences, and Dr. Tahani Al Qadiri, Director — Emiratization and Academics at Burjeel Holdings.

Our partnership with Abu Dhabi University underscores our commitment to advancing medical education and clinical research. This collaboration will open up unparalleled training opportunities for health sciences students, equipping a new generation of healthcare professionals with the knowledge and skills to drive excellence and innovation in the field.
Mr. Safeer Ahamed
Group COO of Burjeel Holdings

The partnership also aims to nurture community knowledge by providing extended programs that focus on higher education and skill development initiatives[N1] [U2] . ADU and Burjeel Holdings will also work together to organize conferences, workshops, seminars, and academic training programs, which will delve into the latest developments and best practices in the field of health sciences.

Furthermore, the MoU will leverage ADU’s leading academic facilities to conduct lectures and training workshops designed to enhance the human resources and administrative practices at Burjeel Holdings. The healthcare provider will also offer internship opportunities throughout its facilities in the UAE to provide ADU students with in-depth practical skills necessary for future careers in healthcare.